Focal lesions in cirrhotic liver: comparing MR imaging during arterial portography with Gd-enhanced dynamic MR imaging.
10.3349/ymj.2000.41.5.546
- Author:
Jeong Sik YU
1
;
Ki Whang KIM
;
Jong Tae LEE
;
Hyung Sik YOO
Author Information
1. Department of Diagnostic Radiology and the Research Institute of Radiological Science, Yonsei University College of Medicine, Seoul, Korea. yjsrad97@yumc.yonsei.ac.kr
- Publication Type:Original Article ; Comparative Study ; Research Support, Non-U.S. Gov't
- Keywords:
Liver neoplasms;
diagnosis;
liver neoplasms;
MR;
comparative studies;
portography
- MeSH:
Adult;
Carcinoma, Hepatocellular/diagnosis;
Comparative Study;
Female;
Gadolinium/diagnostic use;
Hepatic Artery/radiography;
Human;
Liver/pathology*;
Liver Cirrhosis/diagnosis*;
Liver Neoplasms/diagnosis;
Magnetic Resonance Imaging/methods*;
Male;
Middle Age;
Portography
- From:Yonsei Medical Journal
2000;41(5):546-555
- CountryRepublic of Korea
- Language:English
-
Abstract:
The purpose of this study was to document the additional value of MR imaging during arterial portography (MRAP) in patients examined with intravenous contrast-enhanced dynamic MR imaging for the assessment of focal lesions in patients with cirrhosis or chronic viral hepatitis. The MR images of 24 patients with 39 hepatocellular carcinomas and 18 benign hepatocellular nodules examined with dynamic MR imaging and MRAP within a 14-day interval were retrospectively reviewed. For 39 hepatocellular carcinomas, MRAP revealed 37 perfusion defects (95%), while dynamic MR imaging demonstrated 35 occurrences of nodular contrast-enhancement (90%) on arterial dominant phases. Among the 11 benign nodules misinterpreted as hepatocellular carcinoma due to their high signal intensities on arterial-dominant phases of dynamic MR imaging, eight (73%) showed intratumoral portal venous perfusion on MRAP and were regarded as benign nodules. As a result of its high sensitivity and its potential ability to enable differentiation of benign and malignant hepatocellular nodules, MRAP can be added to dynamic MR imaging for planning future management in patients with equivocal hepatocellular nodules in the cirrhotic liver.
